ArticleTherapeutic advances in musculoskeletal disease2026
A snapshot of subcutaneous infliximab uses in inflammatory rheumatic diseases: a multicentric Italian study.
Stefano Gentileschi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.